Yong-su H. Zhen

Beijing, 100700, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

The development of translation between Chinese and ancient Tibetan medical texts

The development of translation between Chinese and ancient Tibetan medical texts

Journal: Zhonghua yi shi za zhi (Beijing, China : 1980)

Published: May 10, 2026

hIMB1636-LDM, a novel anti-TROP2 ADC, exerts potent antitumor efficacy in pancreatic cancer via direct cytotoxicity and immune activation.

hIMB1636-LDM, a novel anti-TROP2 ADC, exerts potent antitumor efficacy in pancreatic cancer via direct cytotoxicity and immune activation.

Journal: Biochemical pharmacology

Published: March 20, 2026

Chronicle of events in the medical history division of the Chinese Medical Association (1996-2023)

Chronicle of events in the medical history division of the Chinese Medical Association (1996-2023)

Journal: Zhonghua yi shi za zhi (Beijing, China : 1980)

Published: May 26, 2025

Chemical coupling of an active/passive dual-targeting fusion protein ER(Fv)-HSA to DM1 improves its tumor-specificity and therapeutic efficacy against pancreatic cancer.

Chemical coupling of an active/passive dual-targeting fusion protein ER(Fv)-HSA to DM1 improves its tumor-specificity and therapeutic efficacy against pancreatic cancer.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: April 14, 2025

The four genres of Sman Thang in Tibetan medicine

The four genres of Sman Thang in Tibetan medicine

Journal: Zhonghua yi shi za zhi (Beijing, China : 1980)

Published: March 26, 2025

h3B7A-LDM, a novel anti-mesothelin antibody-drug conjugate with the potential to induce antitumor immunity, shows potent efficacy against solid tumors.

h3B7A-LDM, a novel anti-mesothelin antibody-drug conjugate with the potential to induce antitumor immunity, shows potent efficacy against solid tumors.

Journal: Journal of pharmaceutical analysis

Published: February 06, 2025

Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics.

Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics.

Journal: International journal of nanomedicine

Published: November 07, 2023

hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer.

hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer.

Journal: Journal of medicinal chemistry

Published: October 26, 2023

A new TROP2-targeting antibody-drug conjugate shows potent antitumor efficacy in breast and lung cancers.

A new TROP2-targeting antibody-drug conjugate shows potent antitumor efficacy in breast and lung cancers.

Journal: NPJ precision oncology

Published: August 30, 2023

Elucidating the development, characterization, and antitumor potential of a novel humanized antibody against Trop2.

Elucidating the development, characterization, and antitumor potential of a novel humanized antibody against Trop2.

Journal: International journal of biological macromolecules

Published: February 07, 2023

The clinical value of using a distant-image screen for reading and learning

The clinical value of using a distant-image screen for reading and learning

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: December 08, 2022

Antitumor efficacy of a recombinant EGFR-targeted fusion protein conjugate that induces telomere shortening and telomerase downregulation.

Antitumor efficacy of a recombinant EGFR-targeted fusion protein conjugate that induces telomere shortening and telomerase downregulation.

Journal: International journal of biological macromolecules

Published: July 05, 2022

Showing 1-12 of 72

Last Updated: 09/26/2026